Key result
Chronic treatment with moxonidine, rilmenidine, and clonidine reduced mean arterial pressure by 13 to 15 mmHg in conscious rabbits, while moxonidine and rilmenidine decreased the vagal contribution to the baroreflex.
Why the study?
Does chronic treatment with moxonidine, rilmenidine, or clonidine alter baroreflex control of heart rate in conscious normotensive rabbits?
Does chronic treatment with moxonidine, rilmenidine, or clonidine alter baroreflex control of heart rate in conscious normotensive rabbits?
p-value: p=<0.05
Second-generation centrally acting antihypertensives moxonidine and rilmenidine chronically shift the balance of baroreflex control of heart rate toward greater sympathetic and lesser vagal influences in normotensive rabbits.
Animal data suggest caution with chronic moxonidine or rilmenidine on vagal baroreflex tone; leaves open translation to hypertensive patients.
We investigated the effects of chronic subcutaneous treatment with centrally-acting antihypertensive agents moxonidine, rilmenidine, and clonidine on the baroreflex control of heart rate (HR) in conscious normotensive rabbits over 3 weeks. Infusions of phenylephrine and nitroprusside were performed at week 0 and at weeks 1 and 3 of treatment to determine mean arterial pressure (MAP)-HR baroreflex relationships. A second curve was performed after intravenous methscopolamine to determine the sympathetic baroreflex relationship. The vagal component of the reflex was determined by subtracting the sympathetic curve from the intact curve. Clonidine and moxonidine (both 1 mg/kg/day), and rilmenidine (5 mg/kg/day), reduced MAP by 13 ± 3, 15 ± 2, and 13 ± 2 mmHg, respectively, but had no effect on HR over the 3-week treatment period. Whilst all three antihypertensive agents shifted baroreflex curves to the left, parallel to the degree of hypotension, moxonidine and rilmenidine decreased the vagal contribution to the baroreflex by decreasing the HR range of the reflex but moxonidine also increased sympathetic baroreflex range and sensitivity. By contrast clonidine had little chronic effect on the cardiac baroreflex. The present study shows that second generation agents moxonidine and rilmenidine but not first generation agent clonidine chronically shift the balance of baroreflex control of HR toward greater sympathetic and lesser vagal influences. These changes if translated to hypertensive subjects, may not be particularly helpful in view of the already reduced vagal contribution in hypertension.
No takes yet. Share an insight, caveat, or question.
Parkin et al. (2016) studied Normotension (animal model) (n=21). Moxonidine, Rilmenidine, and Clonidine vs. Saline vehicle was evaluated on Mean arterial pressure (MAP) and MAP-HR baroreflex relationships (p=<0.05). Chronic treatment with moxonidine, rilmenidine, and clonidine reduced mean arterial pressure by 13 to 15 mmHg in conscious rabbits, while moxonidine and rilmenidine decreased the vagal contribution to the baroreflex.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: